Approval · Notice of Compliance 37503 · 2026
INCRELEX: Notice of Compliance 37503
Issued May 8, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37503
- Date
- May 8, 2026
- Company
- Esteve Pharmaceuticals S.A.Barcelona, Barcelona, Spain
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative – Changes in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INCRELEX | 02509733 | Marketed |
Medicinal ingredients
- MECASERMIN 10 MG per ML